CSIMarket
 


Bionik Laboratories Corp   (BNKL)
Other Ticker:  
 
 

BNKL's Operating Income Growth by Quarter and Year

Bionik Laboratories 's Operating Income results by quarter and year




BNKL Operating Income (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter March -1.30 0.74 -8.87 -2.98
III Quarter December -1.04 -1.04 -1.47 -3.12
II Quarter September -1.11 -0.80 -1.90 -1.83
I Quarter June -1.37 -1.10 -2.34 -1.80
FY   -4.82 -2.20 -14.58 -9.73



BNKL Operating Income fourth quarter 2023 Y/Y Growth Comment
Bionik Laboratories Corp in the fourth quarter 2023 recorded Operating Loss of $ -1.30 millions.

According to the results reported in the fourth quarter 2023, Bionik Laboratories Corp achieved the best Operating Income growth in Medical Equipment & Supplies industry. While Bionik Laboratories Corp ' s Operating Income no change of % ranks overall at the positon no. in the fourth quarter 2023.

Explain Operating Income growth


BNKL Operating Income ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter March - - - -
III Quarter December - - - -
II Quarter September - - - -
I Quarter June - - - -
FY   - - - -

Financial Statements
Bionik Laboratories 's fourth quarter 2023 Operating Income $ -1.30 millions BNKL's Income Statement
Bionik Laboratories 's fourth quarter 2022 Operating Income $ 0.74 millions Quarterly BNKL's Income Statement
New: More BNKL's historic Operating Income Growth >>


BNKL Operating Income (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter March - - - -
III Quarter December - - - -
II Quarter September - - - -
I Quarter June - - - -
FY (Year on Year)   - - - -




Operating Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Operating Income fourth quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Operating Income Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Operating Income by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Bionik Laboratories 's Q/Q Operating Income Growth


Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BNKL's IV. Quarter Q/Q Operating Income Comment
Current results of -1.30 millions by Bionik Laboratories Corp come out even worse considering the Operating Loss -1.04 millions in the third quarter.

Within Medical Equipment & Supplies industry Bionik Laboratories Corp achieved highest sequential Operating Income growth. While Bionik Laboratories 's Operating Income growth quarter on quarter, overall rank is .


Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #
Operating Income Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BNKL's IV. Quarter Q/Q Operating Income Comment
Current results of -1.30 millions by Bionik Laboratories Corp appear even less good if you take a look at -1.04 millions a quarter before.

Within Medical Equipment & Supplies industry Bionik Laboratories Corp achieved highest sequential Operating Income growth. While Bionik Laboratories 's Operating Income growth quarter on quarter, overall rank is .


Bionik Laboratories 's 12 Months Operating Income Growth Year on Year


Operating Income TTM Growth

12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
Cumulative Operating Income 12 Months Ending $ -4.83 $ -2.79 $ -2.79 $ -2.48 $ -2.20
Y / Y Operating Income Growth (TTM) - - - - -
Year on Year Operating Income Growth Overall Ranking # # # # #
Seqeuential Operating Income Change (TTM) - - - - -
Seq. Operating Income Growth (TTM) Overall Ranking # # # # #




Cumulative Operating Income growth Comment
Bionik Laboratories Corp ' has realized cumulative trailing twelve months Operating Loss of $ -5 millions in the Mar 31 2023 period.
The results are getting worse as the cumulative Operating Loss is getting bigger from $ -2.79 millions in the twelve months ending a quarter before and $ -11.811451 millions for the twelve months ending in the quarter a year ago Isabel Clark told.

Bionik Laboratories Corp achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Operating Income growth Comment
Bionik Laboratories Corp ' has realized cumulative trailing twelve months Operating Loss of $ -5 millions in the Mar 31 2023 period.
The results are getting worse as the cumulative Operating Loss is getting bigger from $ -2.79 millions in the twelve months ending a quarter before and $ -11.811451 millions for the twelve months ending in the quarter Mar 31 2022.

Bionik Laboratories Corp achieved highest trailing twelve month year on year Operating Income growth. While overall Operating Income growth ranking, remained unchanged compare to the previous quarter at no. .

Operating Income TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #
Healthcare Sector #
Overall #

Operating Income TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Operating Income TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Operating Income Growth
Medical Equipment & Supplies Industry Operating Income Growth Trends and Statistics
Healthcare Sector Operating Income Growth Statistics
Operating Income Growth Trends for overall market
BNKL's Operating Income Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Operating Income Growth
Lowest Ranking Operating Income Growth
Operating Income Growth for BNKL's Competitors
Operating Income Growth for Bionik Laboratories 's Suppliers
Operating Income Growth for BNKL's Customers

You may also want to know
BNKL's Annual Growth Rates BNKL's Profitability Ratios BNKL's Asset Turnover Ratio BNKL's Dividend Growth
BNKL's Roe BNKL's Valuation Ratios BNKL's Financial Strength Ratios BNKL's Dividend Payout Ratio
BNKL's Roa BNKL's Inventory Turnover Ratio BNKL's Growth Rates BNKL's Dividend Comparisons



Companies with similar Operating Income no change for the quarter ending Mar 31 2023 within Healthcare SectorY/Y Change %Operating Income for the quarter ending Mar 31 2023
Lemaitre Vascular Inc -0.68%$ -0.681 millions
Orgenesis Inc -0.96%$ -0.958 millions
United Therapeutics Corporation-1.25%$ -1.250 millions
Cardiff Lexington Corporation-1.36%$ -1.355 millions
Utah Medical Products Inc-1.84%$ -1.835 millions
Phibro Animal Health Corporation-3.34%$ -3.340 millions
Becton Dickinson And Company-3.68%$ -3.681 millions
Iqvia Holdings Inc -4.85%$ -4.848 millions
Intuitive Surgical Inc -5.02%$ -5.023 millions
Organon and Co -5.19%$ -5.195 millions
Tenet Healthcare Corp-6.94%$ -6.944 millions
Davita Inc -7.88%$ -7.881 millions
Zoetis Inc -10.17%$ -10.165 millions
Bio techne Corp-11.32%$ -11.317 millions
Edwards Lifesciences Corporation-11.49%$ -11.486 millions
Amedisys Inc -11.64%$ -11.640 millions
Lifevantage Corp-12.38%$ -12.384 millions
Viemed Healthcare Inc -13.97%$ -13.968 millions
Biogen Inc -16.87%$ -16.866 millions
West Pharmaceutical Services Inc -18.13%$ -18.134 millions
Chemed Corporation-18.52%$ -18.523 millions
Biomx Inc -20.27%$ -20.267 millions
Integra Lifesciences Holdings Corp-21.19%$ -21.190 millions
Dariohealth Corp -21.82%$ -21.825 millions
Community Health Systems Inc -22.22%$ -22.222 millions
National Research Corporation-22.92%$ -22.920 millions
Amgen Inc -23.16%$ -23.160 millions
Pediatrix Medical Group Inc -23.18%$ -23.185 millions
3m Company-24.38%$ -24.375 millions
Avantor Inc -24.69%$ -24.691 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com